Showing results (251-260 of 408) with videos related to
Sort By:
Pageof 41
European Journal of Clinical Investigation|July 14, 2011
Pravastatin for thioacetamide-induced hepatic failure and encephalopathyHui-Chun Huang, Ching-Chih Chang, Sun-Sang Wang, et al.Journal of the Chinese Medical Association : JCMA|October 20, 2009
Dexamethasone inhibits tumor necrosis factor-alpha-stimulated gastric epithelial cell migrationJiing-Chyuan Luo, Chi-Hin Cho, Ka-Man Ng, et al.Liver International : Official Journal of the International Association for the Study of the Liver|October 24, 2009
Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinomaTeh-Ia Huo, Chia-Yang Hsu, Yi-Hsiang Huang, et al.Journal of the Chinese Medical Association : JCMA|February 6, 2007
Role of hepatic nitric oxide synthases in rats with thioacetamide-induced acute liver failure and encephalopathyHui-Chun Huang, Sun-Sang Wang, Cho-Yu Chan, et al.Journal of the Chinese Medical Association : JCMA|January 22, 2013
Risk factors for upper gastrointestinal bleeding in coronary artery disease patients receiving both aspirin and clopidogrelKuang-Wei Huang, Jiing-Chyuan Luo, Hsin-Bang Leu, et al.British Journal of Clinical Pharmacology|June 12, 2013
Risk of oral antifungal agent-induced liver injury in TaiwaneseWei-Yu Kao, Chien-Wei Su, Yi-Shin Huang, et al.Journal of Clinical Gastroenterology|April 10, 2014
Radiofrequency ablation is better than surgical resection in patients with hepatocellular carcinoma within the Milan criteria and preserved liver function: a retrospective study using propensity score analysesYun-Hsuan Lee, Chia-Yang Hsu, Chen-Wei Chu, et al.Journal of the Chinese Medical Association : JCMA|March 23, 2017
Decoy receptor 3 analogous supplement protects steatotic rat liver from ischemia-reperfusion injuryTzu-Hao Li, Chih-Wei Liu, Pei-Chang Lee, et al.Journal of Gastroenterology and Hepatology|October 4, 2016
ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD EraPo-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, et al.Cancer|June 22, 2010
Selecting an optimal staging system for hepatocellular carcinoma: comparison of 5 currently used prognostic modelsChia-Yang Hsu, Cheng-Yuan Hsia, Yi-Hsiang Huang, et al.Pageof 41